Therefore, our study provides novel insights into the molecular mechanism regulating Wnt5a/Ca2+ in the pathogenesis of CAVD, targeting ECH1 may prove of therapeutic potential to aortic valve calcification. The gene discussed is WNT5A; the disease is aortic valve calcification.